Soma is the brand name for carisoprodol, a prescription muscle relaxant used to treat short-term pain from muscle injuries like sprains and strains. It’s classified as a Schedule IV controlled substance due to its potential for abuse and dependence. Though it’s marketed as a muscle relaxant, carisoprodol actually belongs to the tranquilizer class of medications, and it works primarily by affecting the brain rather than the muscles themselves.
How Soma Works
Soma is a centrally acting muscle relaxant, meaning it reduces muscle pain and spasm by changing how your brain processes pain signals rather than acting directly on the muscle tissue. It works on the same brain receptors that respond to sedatives like barbiturates. Specifically, it both amplifies the activity of your brain’s main calming chemical (GABA) and can activate those receptors on its own, producing sedation and relaxation.
Once you take Soma, your liver converts it into a substance called meprobamate, which is an older anti-anxiety drug. This metabolite contributes to the sedative and calming effects people feel, and it sticks around in your body much longer than carisoprodol itself. While carisoprodol clears out in about 2 hours, meprobamate has a half-life of roughly 10 hours, meaning its effects linger well after the initial dose wears off.
What It’s Prescribed For
Soma is FDA-approved only for short-term relief of discomfort from acute musculoskeletal conditions. It’s intended to be used alongside rest, physical therapy, and other recovery measures following strains, sprains, and muscle injuries. The recommended dose is 250 to 350 mg taken three times a day and at bedtime.
The key limitation: Soma is not meant for long-term use. The maximum recommended treatment duration is two to three weeks. This short window exists because the drug carries real risks of dependence, and there’s limited evidence supporting its effectiveness beyond that timeframe.
How Quickly It Takes Effect
Soma is absorbed quickly after you swallow it, with effects typically beginning within 30 minutes to an hour. It reaches its peak concentration in your blood at about 1.5 to 1.7 hours, depending on the dose. This relatively fast onset is part of what makes the drug appealing but also part of what contributes to its abuse potential.
Common Side Effects
Drowsiness is the most frequently reported side effect and is essentially built into how the drug works. Because Soma acts as a central nervous system depressant, feeling sleepy or sluggish is a predictable result rather than an unusual reaction. This drowsiness often improves as your body adjusts over the first few days of treatment.
Soma requires extra caution if you have kidney or liver disease, since impaired organ function slows the drug’s removal from your body and can intensify its effects. People with a history of seizures should also be aware that carisoprodol may worsen that condition. It’s completely contraindicated in people with porphyria, a rare enzyme disorder.
Dangerous Combinations
Mixing Soma with alcohol, opioids, benzodiazepines, or other sedating medications is one of the most serious risks associated with the drug. The FDA lists carisoprodol alongside benzodiazepines and other central nervous system depressants, warning that combining these substances can cause profound sedation, dangerously slowed breathing, coma, and death.
This isn’t a theoretical concern. FDA analysis of overdose deaths involving opioids found that muscle relaxants like Soma were contributory factors in many cases. The combination creates a compounding sedative effect where each drug amplifies the other’s ability to suppress breathing. Warning signs of a dangerous interaction include unusual dizziness, extreme sleepiness, slowed or labored breathing, and unresponsiveness.
Abuse Potential and Controlled Status
Soma was not always a controlled substance. For years it was prescribed without the same regulatory oversight applied to drugs like benzodiazepines, even though its primary metabolite, meprobamate, had been a controlled substance for decades. The DEA changed that in January 2012, placing carisoprodol into Schedule IV, which means prescriptions now carry stricter requirements around refills and record-keeping.
The drug’s abuse potential comes from both its sedative, euphoria-producing effects and its rapid onset. People who misuse Soma often take it in combination with opioids and benzodiazepines, a combination sometimes called the “Holy Trinity” in substance abuse contexts, to amplify the high from each drug.
Withdrawal Symptoms
Stopping Soma abruptly after taking large doses or using it for an extended period can trigger a withdrawal syndrome. Symptoms include insomnia, vomiting, tremors, muscle twitching, anxiety, and problems with coordination. In more severe cases, hallucinations and delusions can occur. This withdrawal pattern is consistent with what you’d expect from a drug that acts on GABA receptors, similar to withdrawal from benzodiazepines or barbiturates. Tapering the dose gradually rather than stopping suddenly reduces the risk and severity of these symptoms.